These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24211314)

  • 41. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
    Swan H; Laitinen P; Kontula K; Toivonen L
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):162-6. PubMed ID: 15720454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypokalemic periodic paralysis, facial dysmorphism and ventricular arrhythmia (clinical triad of Andersen-Tawil syndrome).
    Thakkar M; Biswas TK; Desle HB
    J Assoc Physicians India; 2012 Nov; 60():56-8. PubMed ID: 23767205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A peculiar case of palpitations and syncope.
    Cheung CC; Scheinman M; Lee BK
    Heart Rhythm; 2022 Mar; 19(3):505-507. PubMed ID: 35227417
    [No Abstract]   [Full Text] [Related]  

  • 44. [Anti-arrhythmia effects of calcium antagonists].
    Gülker H; Ketteler T
    Z Kardiol; 1989; 78 Suppl 5():49-54. PubMed ID: 2698564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.
    Rujirachun P; Junyavoraluk A; Pithukpakorn M; Suktitipat B; Winijkul A
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12798. PubMed ID: 32959505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of sodium and calcium channel block in unmasking the Brugada syndrome.
    Fish JM; Antzelevitch C
    Heart Rhythm; 2004 Jul; 1(2):210-7. PubMed ID: 15851155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obstetric management of a patient with Andersen-Tawil syndrome: A case report.
    Inagaki M; Tatsumi T; Yomogita H; Hirose A; Kubo T; Sekiguchi M; Miyasaka N
    J Obstet Gynaecol Res; 2021 Jan; 47(1):446-451. PubMed ID: 33205612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
    Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
    J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Verapamil: a calcium-channel blocker.
    Bourget C
    Dimens Crit Care Nurs; 1982; 1(3):134-8. PubMed ID: 6282551
    [No Abstract]   [Full Text] [Related]  

  • 50. [Andersen-Tawil syndrome: a review of its clinical and genetic diagnosis with emphasis on cardiac manifestations].
    Márquez MF; Totomoch-Serra A; Vargas-Alarcón G; Cruz-Robles D; Pellizzon OA; Cárdenas M
    Arch Cardiol Mex; 2014; 84(4):278-85. PubMed ID: 25270337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.
    Osadchii OE
    Scand Cardiovasc J; 2016; 50(1):28-35. PubMed ID: 26402340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anti-arrhythmia therapy with Ca++-antagonists].
    Fazekas T
    Orv Hetil; 1989 Jun; 130(23):1195-200. PubMed ID: 2660063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vanishing Weakness and Persistent Cardiac Dysrhythmia: Are We Dealing with Andersen Tawil Syndrome?
    Jhansi Rani P; Yashodhara P; Sundarachary NV; Veeramma U; Elahi SM; Amalakanti S; Lalitha A
    Indian J Pediatr; 2015 Jul; 82(7):642-4. PubMed ID: 25616308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A family with Andersen-Tawil syndrome and dilated cardiomyopathy.
    Schoonderwoerd BA; Wiesfeld AC; Wilde AA; van den Heuvel F; Van Tintelen JP; van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Heart Rhythm; 2006 Nov; 3(11):1346-50. PubMed ID: 17074642
    [No Abstract]   [Full Text] [Related]  

  • 56. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome.
    Sumitomo N; Shimizu W; Taniguchi K; Hiraoka M
    Heart Rhythm; 2008 Mar; 5(3):498-9. PubMed ID: 18313615
    [No Abstract]   [Full Text] [Related]  

  • 57. Electrophysiology and antiarrhythmic effects of calcium antagonists.
    Russell DC
    Scott Med J; 1981 Apr; 26(2):161-4. PubMed ID: 6270786
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prevalence of cardiac arrhythmias in internal medicine diseases].
    Perings C; Strauer BE
    Internist (Berl); 1993 May; 34(5):399-408. PubMed ID: 8099573
    [No Abstract]   [Full Text] [Related]  

  • 59. [When and how to treat ventricular ectopic beats].
    D'Este D; Sorbo MD
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):21S-26S. PubMed ID: 21416822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The development and clinical testing of antiarrhythmia drugs of a new chemical class].
    Petrov VI; Spasov AA; Anisimova VA; Kirillov OV
    Vestn Ross Akad Med Nauk; 2003; (12):15-20. PubMed ID: 14724966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.